Yifan Pharmaceutical Co., Ltd. (002019.SZ) released a profit for its full year that Increases, from last year
The company's bottom line came in at RMB402.02 million, or RMB0.33 per share. This compares with RMB385.96 million, or RMB0.32 per share, last year.
Excluding items, Yifan Pharmaceutical Co., Ltd. reported adjusted earnings of RMB324.79 million or RMB0.27 per share for the period.
The company's revenue for the period fell 0.5% to RMB5.132 billion from RMB5.159 billion last year.
Yifan Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB402.02 Mln. vs. RMB385.96 Mln. last year.-EPS: RMB0.33 vs. RMB0.32 last year.-Revenue: RMB5.132 Bln vs. RMB5.159 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.